Vulnerability to Extreme Heat in Metropolitan Phoenix: Spatial, Temporal, and Demographic Dimensions

由 Chow, W.T.L., Chuang, W.-C., Gober, P.
出版 2014

A mobile pet wearable computer and mixed reality system for human-poultry interaction through the internet

由 Lee, S.P., Cheok, A.D., James, T.K.S., Debra, G.P.L., Jie, C.W., Chuang, W., Farbiz, F.
出版 2014

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients

由 Patel K., Thompson A., Chuang W., Lee C., Peng C., Shanmuganathan G., Thongsawat S., Tanwandee T., Mahachai V., Pramoolsinsap C., Cho M., Han K., Shah S., Foster G., Clark P., Pulkstenis E., Subramanian G., Mchutchison J.
出版 2017

APASL consensus statements and management algorithms for hepatitis C virus infection

由 Omata, M., Kanda, T., Yu, M.-L., Yokosuka, O., Lim, S.-G., Jafri, W., Tateishi, R., Hamid, S.S., Chuang, W.-L., Chutaputti, A., Wei, L., Sollano, J., Sarin, S.K., Kao, J.-H., McCaughan, G.W.
出版 2016

Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection

由 Colvin,R.A., Tanwandee,T., Piratvisuth,T., Thongsawat,S., Hui,A., Zhang,H., Ren,H., Chen,P., Chuang,W., Sobhonslidsuk,A., Li,R., Qi,Y., Præstgaard,J.T., Han,Y., Xu,J., Stein,D.S., Chien,R., Flisiak,R., Jabłkowski,M.S., Liaw,Y., Sung,J.J.Y.
出版 2015

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

由 Pianko S., Zeuzem S., Chuang W.-L., Foster G.R., Sarin S.K., Flisiak R., Lee C.-M., Andreone P., Piratvisuth T., Shah S., Sood A., George J., Gould M., Komolmit P., Thongsawat S., Tanwandee T., Rasenack J., Li Y., Pang M., Yin Y., Feutren G., Jacobson I.M.
出版 2014